Founder Alicia Liu Continues to Build a Performance-Oriented Adult Music Community in New York. New York, NY, United States, June 18, 2026 — Music Pathway Choir presented a musical-theater-themed ...

The complement system has an important role in physiological bone healing, as studied mainly in animal models and local bone tissues. However, the role of the complement system in human fractures, ...

C3 glomerulopathy (C3G) and immune complex membranoproliferative glomerulonephritis (IC-MPGN) are rare kidney conditions caused by an overactive complement system, part of the immune system. C3G ...

Quantum computers—devices that process information using quantum mechanical effects—have long been expected to outperform classical systems on certain tasks. Over the past few decades, researchers ...

Readers discuss ways to rescue the industry. To the Editor: Re “Stop Mutilating Classical Music to Sell It to Kids,” by Evan Shinners (Opinion guest essay, Jan. 23): Mr. Shinners’s essay makes an ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Animals depend on their sense of smell to locate food, identify mates and evade danger. In mammals, olfactory perception typically relies on G protein–coupled receptor (GPCR) pathways. Insects, by ...

Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said. The integration is underway, and the companies are ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

He sits squarely in front of us on the screen, a full-bodied man with a carefully trimmed white beard and a nearly bald head, his eyes looming behind dark-framed glasses—one eye glaring with cyclopean ...

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...